OMER
Price
$4.29
Change
+$0.14 (+3.37%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
283.11M
64 days until earnings call
TGTX
Price
$29.73
Change
+$0.40 (+1.36%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
4.65B
58 days until earnings call
Interact to see
Advertisement

OMER vs TGTX

Header iconOMER vs TGTX Comparison
Open Charts OMER vs TGTXBanner chart's image
Omeros
Price$4.29
Change+$0.14 (+3.37%)
Volume$14.77K
Capitalization283.11M
TG Therapeutics
Price$29.73
Change+$0.40 (+1.36%)
Volume$23.15K
Capitalization4.65B
OMER vs TGTX Comparison Chart in %
Loading...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMER vs. TGTX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMER is a StrongBuy and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (OMER: $4.16 vs. TGTX: $29.33)
Brand notoriety: OMER and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OMER: 41% vs. TGTX: 87%
Market capitalization -- OMER: $291.96M vs. TGTX: $4.72B
OMER [@Biotechnology] is valued at $291.96M. TGTX’s [@Biotechnology] market capitalization is $4.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMER’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • OMER’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both OMER and TGTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMER’s TA Score shows that 2 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • OMER’s TA Score: 2 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, both OMER and TGTX are a bad buy in the short-term.

Price Growth

OMER (@Biotechnology) experienced а -5.45% price change this week, while TGTX (@Biotechnology) price change was -0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

OMER is expected to report earnings on Nov 05, 2025.

TGTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($4.65B) has a higher market cap than OMER($283M). TGTX YTD gains are higher at: -2.558 vs. OMER (-57.895). TGTX has higher annual earnings (EBITDA): 97.6M vs. OMER (-125.18M). TGTX has more cash in the bank: 252M vs. OMER (28.7M). OMER has less debt than TGTX: OMER (184M) vs TGTX (254M). TGTX has higher revenues than OMER: TGTX (454M) vs OMER (0).
OMERTGTXOMER / TGTX
Capitalization283M4.65B6%
EBITDA-125.18M97.6M-128%
Gain YTD-57.895-2.5582,263%
P/E RatioN/A77.18-
Revenue0454M-
Total Cash28.7M252M11%
Total Debt184M254M72%
FUNDAMENTALS RATINGS
OMER vs TGTX: Fundamental Ratings
OMER
TGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
10084
SMR RATING
1..100
1136
PRICE GROWTH RATING
1..100
5464
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OMER's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for TGTX (83). This means that OMER’s stock grew somewhat faster than TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as OMER (100). This means that TGTX’s stock grew similarly to OMER’s over the last 12 months.

OMER's SMR Rating (11) in the Biotechnology industry is in the same range as TGTX (36). This means that OMER’s stock grew similarly to TGTX’s over the last 12 months.

OMER's Price Growth Rating (54) in the Biotechnology industry is in the same range as TGTX (64). This means that OMER’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for OMER (100). This means that TGTX’s stock grew significantly faster than OMER’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMERTGTX
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
82%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
87%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 5 days ago
78%
Aroon
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALSX36.57-0.03
-0.08%
Value Line Select Growth Fund
NWHHX16.27-0.02
-0.12%
Nationwide Bailard Cogntv Val Instl Svc
RMFCX60.44-0.13
-0.21%
American Funds American Mutual R3
AFEGX56.92-0.39
-0.68%
American Century Large Cap Equity G
IGMSX8.28-0.07
-0.84%
Voya Global Insights Portfolio S

OMER and

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with INM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
-1.65%
INM - OMER
46%
Loosely correlated
+1.83%
ACIU - OMER
33%
Loosely correlated
-0.49%
TGTX - OMER
32%
Poorly correlated
+1.28%
MDXG - OMER
32%
Poorly correlated
-1.11%
FULC - OMER
32%
Poorly correlated
-2.56%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with KRYS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+1.28%
KRYS - TGTX
40%
Loosely correlated
-2.03%
CLLS - TGTX
36%
Loosely correlated
-1.04%
OMER - TGTX
33%
Loosely correlated
-1.65%
ACLX - TGTX
33%
Poorly correlated
-1.22%
ROIV - TGTX
33%
Poorly correlated
-0.08%
More